This contract involves the purchase and ongoing supply of laboratory reagents for immunohematology, immunochemistry, and immunohistochemistry testing. It includes the leasing of necessary equipment for these tests at the SPS ZOZ laboratory in Lębork, Poland. The supplier is responsible for transport
Tender closed on 8 Aug 2025. Awaiting award.
No single supplier dominates the field.
In healthcare medical, INDEPENDENT PUBLIC SPECIALIZED HEALTHCARE FACILITY has awarded 4 contracts to 4 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves the purchase and ongoing supply of laboratory reagents for immunohematology, immunochemistry, and immunohistochemistry testing. It includes the leasing of necessary equipment for these tests at the SPS ZOZ laboratory in Lębork, Poland. The supplier is responsible for transport
This contract involves the purchase and ongoing supply of laboratory reagents for the Pathology Laboratory and Analytical Laboratory, including the leasing of analyzers, for the Emergency Medical Service in Lębork. The supplier is responsible for transportation and assumes all costs and risks. Along
This contract involves the procurement and ongoing delivery of food products to the Independent Public Specialist Healthcare Facility in Lębork, Poland. The supplier is responsible for the transportation and associated costs and risks. A detailed list of the required food products is provided in the
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
